FDA approves pancreatic cancer drug that extends patients’ lives - The Washington Post

The Food and Drug Administration has approved a new pancreatic cancer drug, a pill that nearly doubled patients average survival times for one of the deadliest cancers when taken instead of chemother… [+3 chars]